F60-F69
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For inclusion into the study a written consent form for the study is necessary signed after informed consent (about the procedure of the study as well as their voluntary involvement and the freedom to terminate the participation at any time) by the adolescent who is above 14 years of age or by the parents for patients who are 13 years of age. All patients need to be between 13 to 17 years of age, they have to fulfill at least probable criteria for a personality disorder based on the International Personality Disorder Examination, conducted by a reliable interviewer. Inclusion criteria for target sample and control sample: Existance of a personality disorder on the Basis of DSM-IV (IPD) Inclusion criteria for target sample: Treatment in dayclinic. Inclusion criteria for Waitinggroup: Existence of a personality disorder and written consent to participate.
Exclusion criteria
Exclusion criteria: Exclusion criteria are missing reading knowledge of the German language; an IQ below 70, a disorder from the schizophrenic spectrum; any other disorders of perception, cognition and affectivity which influence neuropsychological testing; a change of medication which influences the CNS during the dayclinic treatment program. Medication which has already been given before inclusion into the program does not fulfill an exclusion criterion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint after 12 weeks of Treatment in the dayclinic. Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP). Katamnese after another 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpouint after another 3 months. Secondary Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP). | — |
Countries
Germany
Contacts
Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters am Klinikum der Universität zu Köln